How do HIV-infected smokers react to cigarette price increases? Evidence from the Aproco-Copilote-ANRS CO8 Cohort

Current HIV Research

Volumn 7, Issue 4, 2009, Pages 462-467

  Peretti Watel, Patrick ^a,b,c   Villes, Virginie ^a,b,c   Duval, Xavier ^a   Collin, Fidéline ^a   Reynes, Jacques ^d   Sobel, Alain ^e   Protopopescu, Camelia ^a,b,c   Chêne, Geneviève ^a   Spire, Bruno ^a,b,c   Raffi, François ^f  

^a INSERM   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c OBSERVATOIRE RÉGIONAL DE LA SANTÉ PROVENCE ALPES CÔTE D AZUR   (France)

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

^e HENRI MONDOR HOSPITAL   (France)

^f HÔTEL DIEU   (France)

Author keywords

Anti tobacco policy; Cohort study; France; Smoking; Socio economic status

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR;

ADULT; AGING; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DEMOGRAPHY; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; FINANCIAL MANAGEMENT; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PREVALENCE; PUBLIC HEALTH SERVICE; SEXUAL TRANSMISSION; SMOKING CESSATION; SOCIAL STATUS; COHORT ANALYSIS; COMMERCIAL PHENOMENA; FRANCE; LONGITUDINAL STUDY; MULTIVARIATE ANALYSIS; PSYCHOLOGICAL ASPECT; SMOKING; SOCIOECONOMICS;

ADULT; COHORT STUDIES; COMMERCE; FEMALE; FRANCE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; PREVALENCE; SMOKING; SOCIOECONOMIC FACTORS;

EID: 69849105575     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016209788680624     Document Type: Article

References (50)

1. Niaura R, Shadel WG, Morrow K, Tashima K, Flanigan T, Abrams DB. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis 2000; 31: 808-812
2. Mamary EM, Bahrs D, Martinez S. Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDs 2002; 16: 39-42. (Pubitemid 34118921)
3. Gritz ER, Vidrine DJ, Lazev AB, Amick BC, Arduino RC. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res 2004; 6: 71-77
4. Duval X, Baron G, Garelik D, et al. Living with HIV, Antiretroviral treatment (ART) experience and tobacco smoking: results from a multi-site cross-sectional study. Antivir Ther 2008; 13: 389-397 (Pubitemid 352016732)
5. Peretti-Watel P, Spire B, Lert F, Obadia Y. [Seropositive people infected through intravenous drug use: an enduring vulnerability]. Rev Prat 2005; 55: 2093-2100
6. Peretti-Watel P, Spire B, Lert F, Obadia Y. Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003). Drug Alcohol Depend 2006; 82: S71-9.
7. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New Engl J Med 1998; 338: 853-860
8. Carrieri P, Spire B, Duran S, et al. Health-related quality of life after 1 year of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2003; 32: 38-47. (Pubitemid 36091483)
9. Lewden C, Salmon D, Morlat P, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol 2005; 34: 121-130 (Pubitemid 40347381)
10. Krentz HB, Kliewer G, Gill MJ. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003. HIV Med 2005; 6: 99-106.
11. Lavole A, Wislez M, Antoine M, Mayaud C, Milleron B, Cadranel J. Lung cancer, a new challenge in the HIV-infected population. Lung Cancer 2006; 51: 1-11. (Pubitemid 43088620)
12. Pantanowitz L, Schlecht HP, Dezube BJ. The growing problem of non-AIDS-defining malignancies in HIV. Curr Opin Oncol 2006; 18: 468-478 (Pubitemid 44199843)
13. Burke M, Furman A, Hoffman M, Marmor S, Blum A, Yust I. Lung cancer in patients with HIV infection: is it AIDS-related? HIV Med 2004; 5: 110-114
14. Spano JP, Massiani MA, Bentata M, et al. Lung cancer in patients with HIV infection and review of the literature. Med Oncol 2004; 21: 109-115 (Pubitemid 39108000)
15. Haigentz M. Aerodigestive cancers in HIV infection. Curr Opin Oncol 2005; 17: 474-478
16. Diaz PT, Wewers MD, Pacht E, Drake J, Nagaraja HN, Clanton TL. Respiratory symptoms among HIV-seropositive individuals. Chest 2003; 123: 1977-1982
17. Powles T, Nelson M, Bower M. HIV-related lung cancer - a growing concern? Int J STD AIDS 2003; 14: 647-651
18. Patel N, Talwar A, Reichert VC, Brady T, Jain M, Kaplan MH. Tobacco and HIV. Clin Occup Environl Med 2006; 5: 193-207.
19. Morris A, Kingsley LA, Groner G, Lebedeva IP, Beard CB, Norris KA. Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men. AIDS 2004; 18: 793-798 (Pubitemid 38535008)
20. Miguez-Burbano MJ, Shor-Posner G, Hadrigan S. Non-tuberculous mycobacteria in HIV-infected patients: geographic, behavioural, and immunological factors. Lancet Infect Dis 2005; 5: 394-395 (Pubitemid 40840730)
21. Kohli R, Lo Y, Homel P. Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV Epidemiologic Research (HER) Study. Clin Infect Dis 2006; 43: 90-98
22. Hirsch HH, Battegay M. HIV-infection HAART (highly-active antiretroviral therapy) and hyperlipidemia. Dtsch Med Wochenschr 2003; 128: 1051-1054
23. Seaberg EC, Munoz A, Lu M, et al. Association between highly active antiretroviral therapy and hypertension in a large cohort of men f ollowed from 1984 to 2003. AIDS 2005; 19: 953-960
24. Levy AR, McCandless L, Harrigan PR, et al. Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS. Lipids Health Dis 2005; 4: 4. (Pubitemid 40397725)
25. Chaloupka F, Weschler H. Price, tobacco control policies and smoking among young adults. J Health Econ 1997; 16: 359-373 (Pubitemid 27293316)
26. Lanoie P, Leclair P. Taxation or regulation: Looking for a good anti-smoking policy. Econ Lett 1998; 58: 85-89 (Pubitemid 128029724)
27. Chaloupka FJ, Warner KE. The economics of smoking. In: Culyer AJ, Newhouse JP, Eds, Handbook of health economics. Amsterdam, Elsevier 2000; pp. 1539-1627
28. Kenkel D, Lillard DR, Mathios A. Smoke or fog? The usefulness of retrospectively reported information about smoking. Addiction 2003; 98: 1307-1313 (Pubitemid 37082824)
29. Peretti-Watel P. Pricing policy and some other predictors of smoking behaviours: an analysis of French retrospective data. Int J Drug Policy 2005; 16: 19-26. (Pubitemid 40128238)
30. Decicca P, Kenkel D, Mathios A. Cigarette taxes and the transition from youth to adult smoking: Smoking initiation, cessation, and participation. J Health Econ 2008; 27: 904-917
31. Carrieri MP, Leport C, Protopopescu C, et al. Factors associated with nonadherence to highly active antiretroviral therapy: A 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase. J Acquir Immune Defic Syndr 2006; 41: 477-485 (Pubitemid 43756165)
32. Peretti-Watel P, Spire B, Schiltz MA, et al. Vulnerability, unsafe sex and non-adherence to HAART: evidence from a large sample of French HIV/AIDS outpatients (VESPA/ANRS 2003). Soc Sci Med 2006; 62: 2420-2433
33. Liang K, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13-22.
34. Peretti-Watel P. [Anti-tobacco policies]. Paris, La Documentation Française 2007.
35. Peretti-Watel P, Spire B, and the ANRS-VESPA group. [AIDS: screening of a chronic disease]. Rennes, Presses ENSP, 2008.
36. Beck F, Gautier A, Guilbert P, Eds. [Health attitudes and behaviors, Health Barometer 2005]. Saint-Denis, INPES 2008.
37. Reynolds B. The experiential discounting task is sensitive to cigarette-smoking status and correlates with a measure of delay discounting. Behav Pharmacol 2005; 17: 133-142 (Pubitemid 43312588)
38. Bickel WK, Odum AL, Madden G. Impulsivity and cigarette smoking; delay discounting in current, never, and ex-smokers. Psychopharmacology 1999; 146: 447-454 (Pubitemid 29513285)
39. Graham H. When life's a drag. London, Her Majesty's Stationery Office 1994.
40. Romano PS, Bloom J, Syme SL. Smoking, social support, and hassles in a urban African-American community. Am J Public Health 1991; 81: 1415-1422
41. Le Houezec J. Nicotine: abused substance and therapeutic agent. J Psychiatry Neurosci 1998; 23: 95-108. (Pubitemid 28193514)
42. Denscombe M. Uncertain identities and health-risking behaviour: the case of young people and smoking in late modernity. Br J Sociol 2001; 52: 157-177 (Pubitemid 33597374)
43. Cohen M, Hoffman RG, Cromwell C, et al. The prevalence of distress in persons with human immunodeficiency virus infection. Psychosomatics 2002; 43: 10-15 (Pubitemid 34214156)
44. Peretti-Watel P, Spire B, Pierret J, Lert F, Obadia Y. Management of HIV-related stigma and adherence to HAART: evidence from a large representative sample of outpatients attending French hospitals (ANRS-EN12-VESPA 2003). AIDS Care 2006; 18: 254-261
45. Bouhnik AD, Carrieri MP, Rey D, et al. Drug injection cessation among HIV-infected injecting drug users. Addict Behav 2004; 29: 1189-1197 (Pubitemid 38962347)
46. Marsh A, McKay S. Poor smokers. London, PSI publishing. 1994.
47. Remler DK. Poor smokers, poor quitters, and cigarette tax regressivity. Am J Public Health 2004; 94: 225-229
48. Franks P, Jerant AF, Leigh JP, et al. Cigarette prices, smoking, and the poor: implications of recent trends. Am J Public Health 2007; 97: 1873-1877 (Pubitemid 351182300)
49. Peretti-Watel P, Seror V, Constance J, Beck F. Cigarettes and social differentiation in France: is tobacco use increasingly concentrated among the Poor? Addiction 2009 (forthcoming).
50. Graham H, Der G. Patterns and predictors of tobacco consumption among women. Health Educ Res 1999; 14: 611-618